Evidence map›Paper›PMID 35070875›Full record

ArticleOpen veterinary journal

Study of the effects of Escherichia coli lipopolysaccharide on innate immunity: The expression profile of TLR4 and CD14 genes in rat liver.

Ammar M Al-Aalim, Ali A Al-Iedani, Mohammad A Hamad

Open access · goldAbstract read
In one paragraph

Article in Open veterinary journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Knocking out Fkbp51 decreases CClCell & bioscience · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ammar M Al-AalimDepartment of Microbiology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq.
Ali A Al-IedaniDepartment of Microbiology, College of Veterinary Medicine University of Basrah, Basrah, Iraq.
Mohammad A HamadDepartment of Microbiology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq.
University of Mosul · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBacterial endotoxin [lipopolysaccharide (LPS)] is essential for bacterial virulence as it has a biphasic effect which is either harmful and leads to aseptic shock and death or assists the body defense mechanisms as it stimulates B-cells activation. Many studies have noted that LPS do their action through activation of CD14/ TLR4 pathways, which occur mainly in liver cells, including Kupffer cells, hepatocytes, and liver sinusoidal endothelial cells, which are responsible for cytokines releases and shows the good or bad LPS effect.

aimThe current study aimed to disclose the expression changes in the profile of innate immunological receptors TLR4 and CD14 in rats' livers after stimulation with LPS.

methodsTen groups of male Wistar albino rats were used to study the effects of two types of LPS [extracted LPS from the local strain of

resultsThe results show that there is a negative effect of ELPS on liver CD14 and TLR4, regardless of the dose and route of administration. On the other hand, the SLPS has an upregulatory impact on the liver gene expression. Also, different times show no effect on the gene expression of the two genes.

conclusionThis study concludes that both LPS types used were able to stimulate the CD14 and TLR4 gene expression in the liver in different doses and routes of injection. Also, this study showed the possibility of using ELPS as an immunomodulator in rats.

Indexed as

Escherichia coli InfectionsAnimalsEndothelial CellsEscherichia coliImmunity, InnateLipopolysaccharide ReceptorsLipopolysaccharidesLiverMaleRatsRats, WistarToll-Like Receptor 4Lipopolysaccharide ReceptorsLipopolysaccharidesTlr4 protein, ratToll-Like Receptor 4CD14Escherichia coli LPSInnate immunityRat liverTLR4

Identifiers

PMID35070875
PMCPMC8770194
OpenAlexW4205422523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.